Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Audientes – Rights issue and new business objectives

By Michael FriisHead of Equities
Audientes

Tegningsperioden med units i Audientes' fortegningsemission startede i dag. I den forbindelse afholdt vi her til eftermiddag et event, hvor Audientes' CEO Steen Thygesen gennemgik de vigtigste punkter i fortegningsemissionen, det forventede brug af ny kapital samt de nye forretningsmæssige mål for perioden 2023-2025.  

I næste uge afholder vi endnu et event, hvor vi vil gå dybere med fortegningsemissionen og mulighederne som investor. Tilmeld dig her: https://www.inderes.dk/videos/audientes-pre-emptive-rights-issue-what-to-do-as-a-shareholder

HC Andersen Capital modtager betaling fra Audientes for en Corporate Visibility/Digital IR aftale. /Michael Friis 17:30, 01-12-2022. 

Recent videos

Clas Ohlson, Audiocast, Q2'25
2025-12-10 09:00 Clas Ohlson
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
2025-12-09 22:11 Herantis Pharma
Aiforia as an Investment | Life Science Night Dec 9, 2025
2025-12-09 22:10 Aiforia Technologies
Orion as an Investment | Life Science Night Dec. 9, 2025
2025-12-09 22:10 Orion
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
2025-12-09 22:09 Aiforia Technologies
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.